Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hofmeister

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cellsNeil J Davie, Joseph T Crossno, Maria G Frid, et al.
Journal of Clinical Microbiology|June 28, 2001
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteinsM J Lodes, R Mohamath, L D Reynolds, et al.
Veterinary and Comparative Oncology|April 14, 2015
Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal<sup>®</sup> , or no closed system transfer device for administration of cancer chemotherapy to a dog modelK Kicenuik, N Northrup, A Dawson, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cellsNeil J Davie, Joseph T Crossno, Maria G Frid, et al.
Journal of Clinical Microbiology|June 28, 2001
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteinsM J Lodes, R Mohamath, L D Reynolds, et al.
Veterinary and Comparative Oncology|April 14, 2015
Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal<sup>®</sup> , or no closed system transfer device for administration of cancer chemotherapy to a dog modelK Kicenuik, N Northrup, A Dawson, et al.
Pageof 4